While previous reports have described challenges in managing CML in patients with other thrombophilic conditions, such as factor V Leiden or antiphospholipid syndrome, the coexistence of protein S deficiency presents unique therapeutic considerations. This evidence concerns the gene F5 and antiphospholipid syndrome.